Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David O. Watson currently holds 88,531 shares of Apellis Pharmaceuticals, Inc. (APLS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David O. Watson has been a net seller of APLS stock. They have purchased $0 and sold $6.0M worth of shares.
David O. Watson's most recent insider trade was on Jan 22, 2026, when they sold 7,832 shares at $21.77 per share.
David O. Watson serves as Executive at Apellis Pharmaceuticals, Inc. (APLS). They have executed 80 insider transactions totaling $6.0M over their tenure at the company.
David O. Watson holds the position of Executive at Apellis Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
David O. Watson has shown a selling trading pattern, with $0 in total purchases and $6.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David O. Watson was on Jan 16, 2024, when they purchased $2.3M worth of APLS shares. This transaction involved 34,533 shares at $66.30 per share.
David O. Watson currently owns 88,531 shares of Apellis Pharmaceuticals, Inc. (APLS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David O. Watson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David O. Watson has 80 Form 4 filings on record as an insider at Apellis Pharmaceuticals, Inc..
Set alerts for David O. Watson and 40,000+ other insiders.